-+ 0.00%
-+ 0.00%
-+ 0.00%

Nortiva Bio Launches Clinical-Stage Biopharmaceutical Company To Develop Long-Acting Oral Medicines

Benzinga·06/18/2026 12:08:25
Listen to the news

Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptive

Company seeks pipeline expansion via industry partnerships